TYLENOL w. CODEINE #3 CIII
Generic Name and Formulations:
Codeine phosphate 30mg, acetaminophen 300mg; tabs; contains sulfites.
Janssen Pharmaceuticals, Inc.
Indications for TYLENOL w. CODEINE #3:
Mild to moderately severe pain.
#3: 1–2 tabs every 4 hours. #4: 1 tab every 4 hours.
Post-op pain management in children who have undergone tonsillectomy and/or adenoidectomy.
Risk of respiratory depression and death related to ultra-rapid metabolizers of codeine (esp. in children in post-op tonsillectomy and/or adenoidectomy). Hepatotoxicity (w. acetaminophen >4g/day). Obstructive sleep apnea. Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, or adrenocortical function. GI or GU obstruction. Addison's disease. Asthma. Drug abusers. Sulfite sensitivity. Elderly. Debilitated. Labor and delivery. Pregnancy (Cat.C). Nursing mothers.
Potentiation with alcohol, general anesthetics, tranquilizers (eg, chlordiazepoxide, sedative-hypnotics), other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics.
Opioid + analgesic.
Drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea, vomiting, constipation, urinary retention, rash; overdosage: respiratory depression, hepatotoxicity.
#3—100, 1000; #4—100, 500
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics